Skip to Main Content

Author Details

Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
2010
55
21
PMIDPaper TitleJournal TitlePublished Year
36690841ASO Visual Abstract: Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Ann Surg Oncol2023
37760460IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.Cancers (Basel)2023
37801341Antitumor Immune Responses in B2M-Deficient Cancers.Cancer Immunol Res2023
37292676The landscape of drug sensitivity and resistance in sarcoma.bioRxiv2023
37395687Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation.J Immunol2023
36725150Adopting shorter radiation regimens: rules of engagement for sarcoma.Lancet Oncol2023
36581724Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Ann Surg Oncol2023
35264439Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy.J Immunother Cancer2022
35676488Potentiating adoptive cell therapy using synthetic IL-9 receptors.Nature2022
35939683Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy.Proc Natl Acad Sci U S A2022
36380037Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors.Nature2022
35307963Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma.Cancer Med2022
35115362Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy.J Immunother Cancer2022
33306984Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.Cancer Cell2021
33908045Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentation.Med Phys2021
33556919Radiotherapy Remains Underused in the Treatment of Soft-Tissue Sarcomas: Disparities in Practice Patterns in the United States.J Natl Compr Canc Netw2021
34720663Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma.Sarcoma2021
33372007Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.Cancer Discov2021
33280128Comparison and evaluation of distortion correction techniques on an MR-guided radiotherapy system.Med Phys2021
31570880Tumour-intrinsic resistance to immune checkpoint blockade.Nat Rev Immunol2020
35122015Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy.Nat Cancer2020
34368780PAK4 inhibition improves PD-1 blockade immunotherapy.Nat Cancer2020
32054730A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.Clin Cancer Res2020
33055240Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.Sci Transl Med2020
33305096Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy.Adv Radiat Oncol2020
32846908Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma.Cancers (Basel)2020
32755981Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database Analysis.J Natl Compr Canc Netw2020
32421448How Technology Is Improving the Multidisciplinary Care of Sarcoma.Am Soc Clin Oncol Educ Book2020
32554891Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs.Phys Med Biol2020
32467343Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.Cancer Discov2020
32197352Tumor Size Matters-Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy.Cancers (Basel)2020
32511325Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach.bioRxiv2020
30573690A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.Clin Cancer Res2019
31436746Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.Am J Clin Oncol2019
30953519Interleukin 32 expression in human melanoma.J Transl Med2019
31095527Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy.Nucl Med Commun2019
30913092Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.Am J Clin Oncol2019
29066161Proton craniospinal irradiation during the third trimester of pregnancy.Pract Radiat Oncol2018
30154193SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study.Cancer Discov2018
29674509Antigen Presentation Keeps Trending in Immunotherapy Resistance.Clin Cancer Res2018
29664796Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.Am J Clin Oncol2018
27354473Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.Clin Cancer Res2017
30613825Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical Trial.JCO Precis Oncol2017
28282278Functio Laesa: Cancer Inflammation and Therapeutic Resistance.J Oncol Pract2017
28529899Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma.Transl Lung Cancer Res2017
27903500Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.Cancer Discov2017
27321035PET-Based Thoracic Radiation Oncology.PET Clin2016
27770976Expanding Tumor Lymphocytic Infiltration as a Prognostic Tool to Patients with NSCLC Who Are Treated with Radiotherapy?J Thorac Oncol2016
2614794199mTc-phytate as a diagnostic probe for assessing inflammatory reaction in malignant tumors.Nucl Med Commun2015
26181727Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer.JAMA Oncol2015
  • 1 - 50 of 55

Recommended Authors

University of Colorado Denver at Anschutz Medical Campus
Career Start Year 2018
Number of shared co-authors 0
Sidney Kimmel Cancer Center at Thomas Jefferson University
Career Start Year 2017
Number of shared co-authors 2
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 1
Juravinski Cancer Centre
Career Start Year 2006
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 3
Universite de Sherbrooke
Career Start Year 2004
Number of shared co-authors 0
MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 5
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 11
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 4
Mayo Clinic Hospital
Career Start Year 1994
Number of shared co-authors 4
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 2
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 3
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 2
Weill Cornell Medical College
Career Start Year 1986
Number of shared co-authors 8
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 4
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 4

Collaborators

University of California Los Angeles (university of california los angeles)
Co-authored papers 17
University of California-Los Angeles
Co-authored papers 13
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 13
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Co-authored papers 13
University of California-Los Angeles
Co-authored papers 12
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 11
University of California-Los Angeles
Co-authored papers 9
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 5
Cedars Sinai Medical Center
Co-authored papers 5
University of California los angeles
Co-authored papers 5
University of California los angeles
Co-authored papers 5
University of California
Co-authored papers 4
University of California los angeles
Co-authored papers 4
University of California los angeles
Co-authored papers 4
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 4
Ruijin Hospital
Co-authored papers 4
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 3
University of Pennsylvania
Co-authored papers 3
Zhongshan Hospital, Fudan University
Co-authored papers 3
University of California los angeles
Co-authored papers 3
University of California-Los Angeles
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Cedars-Sinai Medical Center
Co-authored papers 2
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 2
University of California Los Angeles
Co-authored papers 2
University of California-Los Angeles
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Siriraj Hospital, Mahidol University
Co-authored papers 2
University of California, Los Angeles (university of california los angeles)
Co-authored papers 2